Thrombolytic Therapy per Protocol — Indicated
✨ The client has an acute ST-elevation myocardial infarction (STEMI) with ST elevation in V3 and V4.
✨ His symptoms began approximately 2 hours ago, placing him within the potential treatment window for fibrinolytic therapy when timely PCI is unavailable.
✨ Thrombolytic medications dissolve the coronary thrombus responsible for acute coronary artery occlusion.
✨ Restoring coronary blood flow limits the amount of irreversible myocardial necrosis.
✨ The markedly elevated troponin T and CK-MB further support acute myocardial injury.
✨ The client must first be screened carefully for contraindications to fibrinolytic therapy, particularly active bleeding and prior intracranial hemorrhage.
✨ Reperfusion should occur as rapidly as possible because prolonged coronary occlusion results in increasing myocardial damage.
✨ Therefore, thrombolytic therapy per protocol is indicated if PCI cannot be provided within the recommended timeframe and no contraindications exist.
Aspirin 325 mg PO — Indicated
✨ Aspirin inhibits platelet aggregation and helps prevent further enlargement of the coronary thrombus.
✨ Aspirin is an important early medication in the management of suspected acute myocardial infarction when no contraindication exists.
✨ The client's STEMI is most likely associated with acute coronary thrombosis following atherosclerotic plaque disruption.
✨ Reducing platelet aggregation helps limit additional coronary artery occlusion.
✨ Aspirin should generally be administered promptly because early antiplatelet therapy improves outcomes in acute coronary syndromes.
✨ A dose in the range represented by 325 mg is appropriate for initial acute treatment according to common ACS protocols.
✨ The nurse should verify that the client does not have an aspirin allergy or another major contraindication.
✨ Therefore, aspirin is clearly indicated for this client's acute STEMI.
Insert IV — Indicated
✨ Reliable intravenous access is essential for a client experiencing an acute STEMI.
✨ IV access permits rapid administration of medications such as nitroglycerin and morphine when clinically appropriate.
✨ It also provides immediate access if the client develops a life-threatening dysrhythmia or hemodynamic instability.
✨ Acute MI can deteriorate rapidly into cardiogenic shock, cardiac arrest, or other serious complications.
✨ IV access is also necessary for many medications used during emergency reperfusion management.
✨ The client's current condition requires continuous monitoring and readiness for emergency treatment.
✨ Establishing vascular access should therefore occur early during emergency stabilization.
✨ The order to insert an IV is indicated.
Digoxin 0.25 mcg PO — Not Indicated
✨ Digoxin is primarily used for selected clients with heart failure or certain supraventricular dysrhythmias such as atrial fibrillation.
✨ The client has sinus rhythm and no documented indication requiring digoxin therapy.
✨ Digoxin does not restore blood flow through an acutely occluded coronary artery.
Q1HR Complete Neurological Checks — Indicated
✨ Frequent neurological assessments are particularly important when a client receives thrombolytic therapy because intracranial hemorrhage is a serious potential complication.
✨ The nurse should establish and monitor the client's level of consciousness and neurological status.
✨ New confusion, decreased consciousness, severe headache, weakness, or speech changes can indicate intracranial bleeding.
✨ Early identification of neurological deterioration allows rapid intervention and evaluation.
✨ Thrombolytic therapy increases bleeding risk because it promotes breakdown of fibrin-containing clots.
✨ Neurological monitoring therefore becomes an important component of the client's safety surveillance following fibrinolytic administration.
✨ The client's baseline neurological status is currently alert and oriented ×3, providing a useful comparison for subsequent assessments.
✨ Therefore, scheduled complete neurological checks are indicated in this treatment plan.
Metoprolol 50 mg PO — Indicated
✨ Metoprolol is a beta₁-adrenergic blocker that reduces heart rate, blood pressure, and myocardial contractility.
✨ These effects decrease myocardial oxygen demand, which can be beneficial during acute myocardial ischemia.
✨ The client has a blood pressure of 162/89 mm Hg, so hypotension is not currently present.
✨ His heart rate of 99/min also does not indicate bradycardia.
✨ Beta-blockers may reduce recurrent ischemia and certain cardiac complications when appropriately used after acute MI.
✨ The nurse should monitor for bradycardia, hypotension, heart block, and signs of heart failure.
✨ The client's history of asthma warrants additional caution because beta-blockers can potentially contribute to bronchospasm, although metoprolol is relatively beta₁-selective.
✨ Therefore, metoprolol is indicated with appropriate assessment and monitoring.
Nitroglycerin Infusion — Indicated
✨ Nitroglycerin causes vasodilation and can reduce myocardial oxygen demand and ischemic chest discomfort.
✨ This client continues to experience severe 8/10 crushing chest pain, making anti-ischemic treatment appropriate.
✨ His blood pressure of 162/89 mm Hg provides adequate pressure for cautious nitrate administration.
✨ The infusion can be titrated according to the client's pain response and blood pressure.
✨ Nitroglycerin reduces preload through venodilation and can decrease cardiac workload.
✨ The nurse must monitor carefully for hypotension and headache during treatment.
✨ Recent use of a phosphodiesterase-5 inhibitor would be an important contraindication that must be assessed before nitrate administration.
✨ Therefore, titrated IV nitroglycerin is indicated for this client's ongoing ischemic symptoms.
Oxygen Therapy — Indicated
✨ The client's oxygen saturation is 90% on room air, demonstrating hypoxemia.
✨ Supplemental oxygen is appropriate during acute MI when oxygen saturation is reduced.
✨ The order specifically directs oxygen administration to maintain saturation above 92%.
✨ Adequate oxygenation supports oxygen delivery to the ischemic myocardium and other vital organs.
✨ The client also reports shortness of breath, further supporting the need for oxygen therapy.
✨ Oxygen saturation should be continuously reassessed and therapy adjusted according to the client's response.
✨ Routine oxygen is unnecessary in adequately oxygenated MI patients, but this client's saturation is clearly below the prescribed target.
✨ Therefore, supplemental oxygen is indicated.
Morphine 0.5 mg IV — Indicated
✨ Morphine may be used cautiously for severe ischemic chest pain that persists despite appropriate anti-ischemic therapy.
✨ This client reports severe 8/10 chest pain, indicating substantial ongoing discomfort.
✨ Morphine provides analgesia and can decrease sympathetic activation associated with severe pain and anxiety.
✨ Reduced sympathetic activity can decrease cardiac workload and myocardial oxygen demand.
✨ IV administration allows rapid onset and careful titration of the medication's effects.
✨ The nurse must monitor blood pressure, respiratory rate, level of consciousness, and oxygen saturation after administration.
✨ Current ACS practice generally reserves morphine for persistent severe pain rather than administering it routinely to every MI patient.
✨ Given the prescribed dose and severe persistent pain, morphine is indicated with careful monitoring.
Cephalexin 500 mg PO — Not Indicated
✨ Cephalexin is an antibiotic used to treat susceptible bacterial infections.
✨ The client has no findings suggesting an active bacterial infection, and his WBC count is normal at 9,000/mm³.
✨ Antibiotic therapy does not treat the coronary occlusion responsible for this client's acute STEMI.